MBRX · Moleculin Biotech, Inc.
$0.71
+0.03 (+5.09%)
At close · Sep 4
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, the Company had an accumulated deficit of $226.5 million since inception and had not yet generated any revenues from operations. Additionally, management anticipates that its cash on hand of $7.3 million as of June 30, 2026, is not sufficient to fund its planned operations for a period of at least one year from when these condensed consolidated financial statements are issued. These factors raise substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$13.83M
Shares
19.48M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Walter V. Klemp | Chairman, President - Chief Executive Officer | $1,345,958 |
| Jonathan Foster | Executive Vice President and Chief Financial Officer | $907,268 |
| Donald Picker | Chief Scientific Officer | $622,919 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Walter V. Klemp | Chairman, President - Chief Executive Officer | $1,458,759 |
| Walter Klemp | CEO | $1,458,759 |
| Jonathan Foster | Executive Vice President and Chief Financial Officer | $989,639 |
| Donald Picker | Chief Scientific Officer | $694,062 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Walter V. Klemp | Chairman, President - Chief Executive Officer | $1,414,598 |
| Walter Klemp | CEO | $1,414,598 |
| Jonathan Foster | Executive Vice President and Chief Financial Officer | $840,642 |
| Donald Picker | Chief Scientific Officer | $599,106 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Walter V. Klemp | Chairman, President - Chief Executive Officer | $1,971,080 |
| Walter Klemp | CEO | $1,971,080 |
| Jonathan Foster | Executive Vice President and Chief Financial Officer | $1,092,252 |
| Donald Picker | Chief Scientific Officer | $699,469 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Walter Klemp | CEO | $1,987,313 |
| Walter V. Klemp | Chairman, President - Chief Executive Officer | $1,987,313 |
| Jonathan Foster | Executive Vice President and Chief Financial Officer | $1,149,177 |
| Donald Picker | Chief Scientific Officer | $682,397 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Walter V. Klemp | Chairman, President - Chief Executive Officer | $1,516,779 |
| Walter Klemp | CEO | $1,516,779 |
| Jonathan Foster | Executive Vice President and Chief Financial Officer | $946,594 |
| Donald Picker | Chief Scientific Officer | $520,327 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Walter Klemp | CEO | $1,801,716 |
| Walter V. Klemp | Chairman, President - Chief Executive Officer | $1,801,716 |
| Jonathan Foster | Executive Vice President and Chief Financial Officer | $838,941 |
| Donald Picker | Chief Scientific Officer | $522,189 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Walter Klemp | CEO | $1,345,675 |
| Walter V. Klemp | Chairman, President - Chief Executive Officer | $1,345,675 |
| Jonathan Foster | Executive Vice President and Chief Financial Officer | $845,689 |
| Donald Picker | Chief Scientific Officer | $439,407 |